Widespread Decline Seen in MMR Vaccination Rates After COVID-19
By Elana Gotkine HealthDay Reporter
THURSDAY, June 5, 2025 -- A widespread decrease in measles-mumps-rubella (MMR) vaccination rates was seen after the COVID-19 pandemic, according to a research letter published online June 2 in the Journal of the American Medical Association.
Ensheng Dong, Ph.D., from Johns Hopkins University in Baltimore, and colleagues generated a standardized dataset with annual county-level vaccination rates for children from 2017 to 2024 for all states in the United States for which this information was available. Spatiotemporal trends in vaccination coverage were examined. The final dataset included at least one year of vaccination data for 2,237 counties across 38 states.
The researchers found a nationwide decline in vaccination rates during the COVID-19 pandemic, with considerable heterogeneity seen within and across states. The county-level mean vaccination rate decreased from 93.92 percent prepandemic to 91.26 percent postpandemic across 2,066 counties in 33 states with both prepandemic and postpandemic vaccination rates, representing a mean decline of 2.67 percent. During this period, 78 percent the 2,066 counties reported a decline in coverage. Only four states reported an increase in the median county-level vaccination rate.
"Our county-level dataset complements the state and national-level CDC data, confirming a widespread decline in MMR vaccination rates in the U.S. after the COVID-19 pandemic while revealing significant heterogeneity in vaccination patterns within and across states," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Further Support and Information on COVID-19
Read this next
Larazotide May Speed Recovery in Children With Multisystem Inflammatory Syndrome
WEDNESDAY, Aug. 6, 2025 -- Treatment of multisystem inflammatory syndrome in children (MISC), a postacute sequela of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)...
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
WEDNESDAY, Aug. 6, 2025 -- Vaccination with the updated COVID-19 mRNA vaccine containing the severe acute respiratory syndrome coronavirus-2 Omicron JN.1 lineage was not...
Prevalence of Disorders of Gut-Brain Interaction Increased After Pandemic
TUESDAY, Aug. 5, 2025 -- The prevalence of disorders of the gut-brain interaction (DGBI) increased from before to after the COVID-19 pandemic, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.